Virogin Biotech

PharmaceuticalsSeries DShenzhen, Chinavirogin.com

Latest round

Series D

Last raised

Sep 2021

Total raised

$262M

Investors

12

About Virogin Biotech

Established in 2015 and based in Shenzhen, China and headquarter in Canada, Virogin Biotech Ltd. is a biomedical company that develops anti-cancer oncolytic viruses vaccine and oncolytic virus (OV) therapeutics. The company engages in the sales and production of anti-cancer oncolytic viruses vaccine and oncolytic virus (OV) therapeutics. In the future, the company will deepen its existing clinical projects, follow-up product pipeline continuous research and development and pre-clinical research, as well as potential strategic cooperation. The company will steadily implement its global clinical development strategy.

Who invested in Virogin Biotech

12 investors across 3 rounds

See all investors in Virogin Biotech

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Sep 24, 2021

    Amount

    $120M

    Investors

    Locked

  2. Series D

    May 7, 2021

    Amount

    $80M

    Investors

    Locked

  3. Series C

    Sep 21, 2020

    Amount

    $62M

    Investors

    Locked

Questions about Virogin Biotech

Who invested in Virogin Biotech?

Virogin Biotech has 12 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Virogin Biotech raised?

Virogin Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Virogin Biotech last raise money?

Virogin Biotech's most recent round on record is a Series D, in Sep 2021.

What does Virogin Biotech do?

Established in 2015 and based in Shenzhen, China and headquarter in Canada, Virogin Biotech Ltd.

Where is Virogin Biotech headquartered?

Virogin Biotech is headquartered in Shenzhen, China.

Which VCs invest in companies like Virogin Biotech?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Virogin Biotech's stage. Their profiles are linked below.

Raising like Virogin Biotech? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.